The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has recently published “Therapeutic and Diagnostic Device Outcomes Research.” This new primer is intended to inform both health outcomes researchers on the unique characteristics of therapeutic and diagnostic devices, and also medical device developers on basic principles of clinical, economic, and patient-reported outcomes research for therapeutic and diagnostic devices.
David Parker, PhD, Vice President, extends Boston Healthcare’s thought leadership in the health care industry with his contribution to the ISPOR primer. Dr. Parker is author or co-author of four chapters in this important reference resource: Chapter 3 - Therapeutic and Diagnostic Device Research and Development: An Overview, Chapter 4 - Therapeutic and Diagnostic Device Clinical Development Costs, Chapter 19 - Drug-Device Combination: Companion Diagnostics, and Chapter 24: Economic Environment for Therapeutic and Diagnostic Devices. A full bibliography of Boston Healthcare's articles, abstracts, posters, and publications can be found on the Boston Healthcare website.
For ordering information, visit the ISPOR site. Click here to email Dr. Parker or request more information, or visit us at the next ISPOR conference on June 2-6 in Washington, D.C.
________________________